https://www.selleckchem.com/pr....oducts/3-methyladeni
11, I2 = 24%, five studies). The exposure to NSAIDs did not increase the risk of severe/critical COVID-19 disease (OR 0.92, 95% CI 0.80-1.05, I2 = 0%, 5 studies) nor all-cause mortality among patients with COVID-19 (OR 0.86, 95% CI 0.75-0.99, I2 = 14%, four studies). Our data did not suggest that exposure to NSAIDs increases the risk of having SARS-CoV-2 infection or increases the severity of COVID-19 disease. Also, the fragility of the studies included precludes definite conclusions and highlights the need for further robust da
Like
Comment
Share
